Top-News
Biotechnologie USA

Atossa Therapeutics Inc News

Aktie
WKN:  A2JJ99 ISIN:  US04962H5063 US-Symbol:  ATOS
1,098 €
+0,038 €
+3,58%
09:43:40 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
125,76 Mio.
Marktkapitalisierung *
136,09 Mio. €
Streubesitz
78,18%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 28.06.2024

Atossa Therapeutics Inc News

26.03.24 - PR Newswire
Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics?
Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics? PR Newswire
20.03.24 - PR Newswire
Thinking about buying stock in Pixelworks, Backblaze, Praxis Precision Medicines, Scworx, or Atossa Therapeutics?
Thinking about buying stock in Pixelworks, Backblaze, Praxis Precision Medicines, Scworx, or Atossa Therapeutics? PR Newswire
30.10.23 - PR Newswire
Quantum Leap Healthcare Collaborative Initiates Landmark Phase 2 RECAST DCIS Platform Trial to Evaluate Alternative DCIS Treatments with Atossa Therapeutics, Havah Therapeutics, and the Menarini Group
Quantum Leap Healthcare Collaborative Initiates Landmark Phase 2 RECAST DCIS Platform Trial to Evaluate Alternative DCIS Treatments with Atossa Therapeutics, Havah ...
11.10.23 - PR Newswire
Fast-food consumption by adolescent girls may sow the seeds of breast cancer decades later
Fast-food consumption by adolescent girls may sow the seeds of breast cancer decades later PR Newswire
04.09.23 - Gurupress
Atossa Genetics Aktie: Rückgang und skeptische Investoren erwarten Quartalsergebnisse
Die Atossa Genetics Aktie hat in den letzten 30 Tagen einen Rückgang von -24,53% verzeichnet. Dies zeigt, dass die Anleger möglicherweise skeptisch sind und auf negative ...
28.06.23 - PR Newswire
Atossa Therapeutics and Quantum Leap Healthcare Provide Enrollment Update for (Z)-Endoxifen Arm of Ongoing I-SPY 2 Clinical Trial
Atossa Therapeutics and Quantum Leap Healthcare Provide Enrollment Update for (Z)-Endoxifen Arm of Ongoing I-SPY 2 Clinical Trial PR Newswire
11.05.23 - PR Newswire
Physician-Scientist Dr. Steven Quay Provides Recommendations to the United States Preventive Services Task Force on Breast Cancer Screening Policies and Practices
Physician-​Scientist Dr. Steven Quay Provides Recommendations to the United States Preventive Services Task Force on Breast Cancer Screening Policies and Practices PR Newswire
21.03.23 - PR Newswire
Atossa Therapeutics and Quantum Leap Healthcare Announce New Study Arm to Evaluate (Z)-Endoxifen in the Ongoing I-SPY 2 Clinical Trial
Atossa Therapeutics and Quantum Leap Healthcare Announce New Study Arm to Evaluate (Z)-Endoxifen in the Ongoing I-SPY 2 Clinical Trial PR Newswire
16.12.21 - PR Newswire
Physician-Scientist Steven Quay Calls for International Effort to Investigate a Coronavirus discovered in Laos by Institut Pasteur
Physician-​Scientist Steven Quay Calls for International Effort to Investigate a Coronavirus discovered in Laos by Institut Pasteur The BANAL-236 coronavirus violates 40 years of ...
30.07.21 - PR Newswire
Thinking about buying stock in Erytech Pharma, NanoVibronix, Atossa Therapeutics, Allied Healthcare, or Camber Energy?
Thinking about buying stock in Erytech Pharma, NanoVibronix, Atossa Therapeutics, Allied Healthcare, or Camber Energy? PR Newswire
26.07.21 - PR Newswire
Physician-Scientist Steven Quay: Forensic examination of Wuhan Institute of Virology COVID-19 patient specimens from December 2019 reveals extensive laboratory contamination, including evidence of genetic manipulation of the Nipah Virus, a BSL-4 pathogen more lethal than Ebola
Physician-​Scientist Steven Quay: Forensic examination of Wuhan Institute of Virology COVID-19 patient specimens from December 2019 reveals extensive laboratory contamination, ...
14.07.21 - PR Newswire
Thinking about buying stock in Ashford Hospitality Trust, Clovis Oncology, Exela Technologies, Wipro, or Atossa Therapeutics?
Thinking about buying stock in Ashford Hospitality Trust, Clovis Oncology, Exela Technologies, Wipro, or Atossa Therapeutics? PR Newswire
02.07.21 - PR Newswire
Thinking about buying stock in Provention Bio, Virgin Galactic, Staffing 360 Solutions, Atossa Therapeutics, or Marin Software?
Thinking about buying stock in Provention Bio, Virgin Galactic, Staffing 360 Solutions, Atossa Therapeutics, or Marin Software? PR Newswire
30.06.21 - PR Newswire
Thinking about buying stock in Check Cap, ContextLogic, Marin Software, Atossa Therapeutics, or Altimmune?
Thinking about buying stock in Check Cap, ContextLogic, Marin Software, Atossa Therapeutics, or Altimmune? PR Newswire
25.06.21 - PR Newswire
Thinking about buying stock in Atossa Therapeutics, ContextLogic, Nokia, Canopy Growth Corp, or Marin Software?
Thinking about buying stock in Atossa Therapeutics, ContextLogic, Nokia, Canopy Growth Corp, or Marin Software? PR Newswire
23.06.21 - PR Newswire
Thinking about buying stock in Acasti Pharma, Globalstar, ContextLogic, Atossa Therapeutics, or Ideanomics?
Thinking about buying stock in Acasti Pharma, Globalstar, ContextLogic, Atossa Therapeutics, or Ideanomics? PR Newswire
22.06.21 - PR Newswire
Thinking about buying stock in vTv Therapeutics, Score Media and Gaming, Bio-Path Holdings, Anavex Life Sciences, or Atossa Therapeutics?
Thinking about buying stock in vTv Therapeutics, Score Media and Gaming, Bio-Path Holdings, Anavex Life Sciences, or Atossa Therapeutics? PR Newswire
21.06.21 - PR Newswire
Thinking about buying stock in MediciNova, Torchlight Energy, Atossa Therapeutics, Globus Maritime, or ContextLogic?
Thinking about buying stock in MediciNova, Torchlight Energy, Atossa Therapeutics, Globus Maritime, or ContextLogic? PR Newswire
09.06.21 - PR Newswire
Thinking about buying stock in BlackBerry, Atossa Therapeutics, UWM Holdings, Farmmi, or Root?
Thinking about buying stock in BlackBerry, Atossa Therapeutics, UWM Holdings, Farmmi, or Root? PR Newswire
08.06.21 - PR Newswire
Thinking about buying stock in BlackBerry, Sonim Technologies, Atossa Therapeutics, Clean Energy Fuels, or Tilray?
Thinking about buying stock in BlackBerry, Sonim Technologies, Atossa Therapeutics, Clean Energy Fuels, or Tilray? PR Newswire

Newssuche

Videos

newspaper
03.07.24 +3,08%
Technical Trading: Bund Future Long Chance
Bund Future Long Typ: Turbo Open End WKN: VM3CG4 Hebel: 7,32 Laufzeit: OpenEnd Einstieg: Market ... Mehr »